Optimal Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$333K Buy
3,088
+4
+0.1% +$457 0.04% 333
2021
Q2
$347K Hold
3,084
0.04% 335
2021
Q1
$334K Buy
+3,084
New +$330K 0.04% 330

Other funds holding ABBV

Optimal Asset Management's ABBV Position: Q3 2021 in Review

Optimal Asset Management increased its AbbVie (ABBV) stake by 0.13% in Q3 2021, buying an estimated $457 and bringing the position to 3,088 shares worth $333K. The position accounts for 0.04% of the portfolio, ranked #333.

Optimal Asset Management first reported a position in ABBV in Q1 2021 and has held it in 3 quarters since. The position peaked at $347K in Q2 2021. 2,655 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

  • Optimal Asset Management held 3,088 shares of AbbVie worth $333K as of Q3 2021.
  • Optimal Asset Management bought 4 AbbVie shares in Q3 2021, an estimated $457.
  • AbbVie made up 0.04% of Optimal Asset Management's portfolio in Q3 2021, its #333 holding.
  • Optimal Asset Management first reported a position in AbbVie in Q1 2021 and has held it in 3 quarters since.
  • Optimal Asset Management's AbbVie position peaked at $347K in Q2 2021.
  • 2,655 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Optimal Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.